Abstract
Mitochondrial DNA (mtDNA) is highly susceptible to mutations that result in polymorphisms and diseases including diabetes. We analyzed heteroplasmy, polymorphisms related to diabetes, and complementation by fusogenic proteins. Cytoplast fusion and microinjection allow, defects in mutated mtDNA inside a heteroplasmic cell to be complemented by fusing two mitochondria via human fusogenic proteins. We characterized three hfzos as well as two OPA1s that prevent apoptosis. Two coiled coil domains and GTPase domains in these fusogenic proteins regulate membrane fusion. The hfzo genes were expressed mainly in the brain and in muscle that are postmitotic, but not in the pancreas. Under the in.uence of polymorphisms of mtDNA and nDNA, the vicious circle of reactive oxygen species and mutations in cell can be alleviated by mitochondrial fusion.
Similar content being viewed by others
REFERENCES
Chomyn, A. and Attardi, G. (2003) MtDNA mutations in aging and apoptosis. Biochem. Biophys. Res. Commun. 304:519–529.
Andrews. R. M., Kubacka. I., Chinnery. P. F., Lightowlers. R. N., Turnbull. D. M., and Howell. N. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 23:147.
Kagawa, Y., Hamamoto, T., Endo, H., Ichida, M., Shibui, H., and Hayakawa, M. (1997) Genes of human ATP synthase: Their roles in physiology and aging. Biosci. Rep. 17:115–146.
Ono, T., Isobe, K., Nakada, K., and Hayashi, JI (2001) Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat. Genet. 28:272–275.
Attardi, G., Enriquez, J. A., and Cabezas-Herrera, J. (2002) Inter-mitochondrial complementation of mtDNA mutations and nuclear context. Nat. Genet. 30: 360–361.
Hayashi, J., Ohta, S., Kikuchi, A., Takemitsu, M., Goto, Y., and Nonaka, I. (1991) Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA. 88:10614–10618.
Kagawa, Y., Inoki, Y.,and Endo, H. (2001) Gene therapy by mitochondrial transfer. Adv Drug Deliv. Rev. 49:107–119.
Inoki, Y. et al. (2000) Proteoliposomes colocalized with endogenous mitochondria in mouse fertilized egg. Biochem. Biophys. Res. Commun. 27:183–191.
Inoue, K. et al. (2000) Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat. Genet. 26: 176–181.
Inoue, K., Ogura, A., and Hayashi, J. (2002) Production of mitochondrial DNA transgenic mice using zygotes. Methods 26: 358–363.
Nakada, K. et al. (2001) Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat. Med. 7:895–896.
Evans, M. J., Curer, C., Loike, J. D., Wilmut, I., Schhnieke, A. E., and Schon, E. A. (1999) Mitochondrial DNA genotypes in nuclear transfer-derived cloned sheep. Nat. Genet 23: 90–93.
Barritt, J. A., Brenner, C. A., Malter, H. E., and Cohen, J. (2001) Mitochondria in human offspring derived from ooplasmic transplantation. Hum. Reprod. 16:513–516.
Kagawa, Y., Cha, S. H., Hasegawa, K., Hamamoto, T., and Endo, H. (1999) Regulation of energy metabolism in human cells in aging and diabetes: F0F1, mtDNA, UCP, and ROS. Biochem. Biophys. Res. Commun. 266:662–676.
Pang, C. W., Lee, H. C., and Wei, Y. H. (2001) Enhanced oxidative damage in mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes. Diabetes Res. Clin. Pract. 54:45–56.
Linnane, A. W., Marzuki, S., Ozawa, T., and Tanaka, M. (1989) Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1:642–645.
Biondokas, V. P., Kuznetsov, A., Sreenan, S., Plonsky, K. S., Roe, M. W., and Phillipson, L.H. (2003) Visualizing superoxide production in normal and diabetic rat islets of Langerhans. J. Biol. Chem. 278:9796–9801.
Kobayashi, Y. et al. (1990) A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes).Biochem. Biophys. Res Commun. 173:816–822.
Goto, Y., Nonaka, I., and Horai, S. (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651–653.
Schoffner, J. M., Lott, M. T., Lezza, A. M., Seibel, P., Ballinger, S. W., and Wallace, D. C. (1990) Myoclonic epilepsy and ragged red fiber disease (MERRF) is associated with the DNAtRNALys mutation. Cell 61:931–937.
Schmiedel, J., Jackson, S., Schafer, J., and Reichmann, H. (2003) Mitochondrial cytopathies. J. Neurol. 250:267–277.
Mimaki, M. et al. (2003) A double mutation (G11778 and G12192A) in mitochondrial DNA associated with Leber's hereditary optic neuropathy and cardiomyopathy. J. Hum. Genet. 48:47–50.
Man, P. Y., Turnbull, D. M. and Chinnery, P.F. (2002) Leber's hereditary optic neuropathy. J. Med. Genet. 39:162–169.
Holt, I. J., Harding, A. E., Petty, R. K., and Morgan-Hughs, J. A. (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46:428–433.
Geromel, V. et al. (2001) Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of mitochondrial DNA. Hum. Mol. Genet. 10:1221–1228.
Taniike, M. et al. (1992) Mitochondrial tRNA Ile mutation in fatal cardiomyopathy. Biochem. Biophys. Res. Commun. 186:47–53.
Yasukawa, T., Suzuki, T., Ueda, T., Ohta, S., and Watanabe, K. (2000) Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs (Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275:4251–4257.
Suzuki, T., Suzuki, T. Wada, T., Saigo, K., and Watanabe, K. (2002) Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21:6581–6589.
Shanske, S. et al. (1990) Widespread tissue distribution of mitochondrial DNA deletions in Kearns– Sayer Syndrome. Neurology 40:24–28.
Kagawa, Y., Yuzaki, M., Ohta, S., Tominaga, K., Ohtsuka, M., and Kanazawa, I. (1991) Multiple deletions of mitochondrial DNA in patients with familial mitochondrial myopathy. Progr. Neuropathol 7:129–139.
Gerhard, G. S. et al. (2002) Mitochondrial DNA mutation analysis in human skin fibroblasts from fetal, young and old donors. Mech. Ageing Devel. 123:156–166.
Fukagawa, N. K., Li, M., Liang, P., Russell, J. C., Sobel, B. E., and Absher, P.M. (1999) Aging and high concentration of glucose potentiate injury to mitochondrial DNA. Free Radic. Biol. Med. 27:1437–1443.
Mirabella, M. D., Giovanni, S., Silvestri, G., Tonali, P., and Servidei, S. (2000) Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain 123:93–104.
Ikezoe, K., Nakagawa, M., Yan, C., Kira, J., Goto, Y., and Nonaka, I. (2002) Apoptosis is suspended in muscle of mitochondrial encephalomyopathies. Acta Neuropathol. 103:531–540.
Guillausseau, P.-J., et al. (2001) Maternally inherited diabetes and deafness: A multicenter study. Ann. Internal Med. 134:721–728.
Tawata, M. (2000) A new mitochondrial DNA point mutation at 14577T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes mellitus. Diabetes 49:1269–1272.
Shiraiwa, N., Ishii, A., Iwamoto, H., Mizusawa, H., Kagawa, Y., and Ohta, S. (1993) Content of mutant mitochondrial DNA and organ-dysfunction in a patient with a MELAS-subgroup of mitochondrial encephalomyopathies. J. Neurol. Sci. 120:174–179.
Jeppesen, T. D., Schwartz, M., Olsen, D. B., and Vissing, J. (2003) Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy. Ann. Neurol. 54:86–92.
Olsson, C., Zethelius, B., Lagerstome-Fermer, M., Asplund, J., Berne, C., and Landegren, U. (1998) Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum. Mutat. 12:52–58.
Szibor M. and Holtz, J. (2003) Mitochondrial aging. Basic Res. Cardiol. 98:210–18.
Calloway, C. D., Reynolds, R. L., Herrin, G. L. Jr. and Anderson, W. W. (2000) The frequency of heteroplasmy in the HVII region of mtDNA differs across tissue types and increase with age. Am. J. Hum. Genet. 66:1384–1397.
Smith, L. C., Bordignon, V., Couto, M. M., Garcia, S. M., Yamazaki, W., and Meirelles, F. V. (2002) Mitochondrial genotype segregation and the bottle neck. Reprod. Biomed. Online. 4:248–255.
Kitagawa, T., Suganuma, N., Nawa, F., Tanaka, M., Ozawa, T., and Tomoda, Y. (1993) Rapid accumulation of deleted mitochondrial deeoxynucleic acid in postmenopausal ovaries. Biol. Reprod. 49:730–736.
Van Blerkom, J., Sinclair, J., and Davis, P. (1998) Mitochondrial transfer between oocytes: potential application of mitochondrial donation and the issue of heteroplasmy. Hum. Reprod. 13:2857–2868.
Dey, R., Barrientos, A., and Moraes, C. T. (2000) Functional constraints of nuclear-mitochondrial DNA interactions in xenomitochondrial rodent cell lines. J. Biol. Chem. 275:31520–31527.
Kagawa, Y. et al. (2002) Single nucleotide polymorphism of thrifty genes for energy metabolism: evolutionary origins and prospects for intervention to prevent obesity-related diseases. Biochem. Biophys. Res. Commun. 295:207–222.
Horai, S. et al. (1996) mtDNA polymorphism in East Asian Populations, with special reference to the peopling of Japan. Am. J. Hum. Genet. 59, 579–590.
Matsunaga. H. et al. (2001) Anti-atherogenic mitochondrial genotype in patients with type 2 diabetes. Diabetes Care 24:500–503
Torroni, A. and Wallace D. C. (1994) Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance. J. Bioenerg. Biomembr. 26:261–271.
Kagawa, Y. (1997) Mitochondrial disease and polymorphism in the genes for energy transduction. In Advances in Research on DNA Polymorphisms (ed. ISFH Hakone Symposium Program Committee) pp. 48–60. Toyoshoten, Tokyo.
Horai, S. (2000) The origin and dispersal of mordern humans: inferred from mitochondrial DNA. (In Japanese) Protein, Nucleic Acid Protein 45:2579–2587.
Yanagisawa, Y. et al. (2001) Uncoupling protein 3 and peroxisome proliferator-activated receptor γ2 contribute to obesity and diabetes in Palauans. Biochem. Biophys. Res. Commun. 281:772–778.
Schurr, T. G. and Wallace D. C. (2002) Mitochondrial DNA diversity in Southeast Asian populations. Hum. Biol. 74:431–452.
Umetsu, K. et al. (2001) Multiplex amplified product-length polymorphism analysis for rapid detection of human mitochondrial DNA variations. Electrophoresis 22:3533–3538.
Tanaka, M., Gong, J., Zhang, J., Yamada, Y., Borgeld, H. J., and Yagi, K. (2000) Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mech. Ageing Dev. 116:65–76.
Carvajal-Carmona, L. G. et al. (2000) Strong Amerind/white sex bias and a possible Sephardic contribution among the founders of a population in northwest Columbia. Am. J. Hum. Genet. 67:1287–1295.
Simmons, D., Gatland, B. A., Leakehe, L., and Fleming, C. (1995) Frequency of diabetes in family members of probands with non-insulin-dependent diabetes mellitus. J. Internal. Med. 237:315–321.
Carelli, V., Giordano, C., and d'Amati, G. (2003) Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 19:257–262.
Ichida, M. et al. (2000) Differential regulation of exonic regulatory elements for muscle-specific alternative splicing during myogenesis and cardiogenesis. J. Biol. Chem. 275:15992–16001.
Hayakawa, M. et al. (2002) Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase γ-subunit pre-mRNA. J. Biol. Chem. 277:6974–6984.
Hayashi, J. et al. (1994) Nuclear but not mitochondrial genome involvement in human age-related mitochondrial dysfunction. Functional integrity of mitochondrial DNA from aged subjects. J. Biol. Chem. 269:6878–6883.
Ito, S., et al. (1999) Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96:2099–2103.
King, M. P. and Attardi, G. (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by repopulation. Science 246:500–503.
Hussain, M. M., Strickland, D. K., and Bakillah, A. (1999) The mammalian low-density lipoprotein receptor family. Ann. Rev. Nutr. 19:142–172.
Hathout, E., Lakey, J., and Shapiro, J. (2003) Islet tansplant: an option for childhood diabetes? Arch. Dis. Child. 88:591–594.
Yoneda. M., Miyatake, T., and Attardi, G. (1994) Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol. Cell Biol. 14:2699–2712.
Hales, K. G. and Fuller, M. T. (1997) Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell 90:121–129.
Hermann, G. J. et al. (1998) Mitochondrial fusion in yeast requires the transmembrane GTPase Fzo1p. J. Cell Biol. 143:359–373.
Sentel, A., Frank, S., Gaume, B., Herrier, M., Youle, R. J., and Fuller, M. T. (2003) Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J. Cell Sci. 116:2763–2774.
Sesaki, H., Southerd, S. M., Yaffe, M. P., and Jensen, R.E. (2003) Mgm1p, a diynamin-related GTPase, is essential for fusion of the mitochondrial outer membrane. Mol. Biol. Cell. 14:2342–2356.
Satoh, M., Hamamoto, T., Seo, N., Kagawa, Y., and Endo, H. (2003) Differential sublocalization of the dynamin-related protein OPA1 isoforms In mitochondria. Biochem. Biophys. Res. Commun. 300:482–493.
Hayashi, J-I. et al. (1994) Functional and morphological abnormalities of mitochondria in human cells containing mitochondrial DNA with pathogenic point mutations in tRNA genes. J. Biol. Chem. 269:19060–19066.
Olichon, A. et al. (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrom c release and apoptorsis. J. Biol. Chem. 278:7743–7746.
Mozdy, A. D. and Shaw, J. M. (2003) A fuzzy mitochondrial fusion apparatus comes into focus. Nat. Rev. Cell Biol. 4:468–478.
Zang, J. et al. (2003) Strikingly higher frequency in centernarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc. Natl. Acad. Sci. USA 100:1116–1121.
Tanaka, M. (2002) Mitochondrial genotypes and cytochrome b variants Associated with longevity or Parkinson's disease. J. Neurol. 249:Suppl 2: 111–118.
Maechler, P. and Wollheim, C. B. (2001) Mitochondrial function in normal and diabetic β-cells. Nature 414:807–812.
Poulton, J. (1998) Does a common mitochondrial DNA polymorphism underlie susceptibility to diabetes and thrifty genotype? Trends Genet. 14:387–389.
Wallace, D. C. (2002) Animal models for mitochondrial disease. Methods Mol. Biol. 197:3–54.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, A., Endo, H., Umetsu, K. et al. Polymorphism, Heteroplasmy, Mitochondrial Fusion and Diabetes. Biosci Rep 23, 313–337 (2003). https://doi.org/10.1023/B:BIRE.0000019189.35983.b9
Issue Date:
DOI: https://doi.org/10.1023/B:BIRE.0000019189.35983.b9